Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guérin for Ta and T1 bladder cancer: a systematic review and meta-analysis.

Lu, Jun-Lin; Xia, Qi-Dong; Liu, Chen-Qian; Sun, Jian-Xuan; Yang, Yuan-Yuan; Hu, Heng-Long; Wang, Shao-Gang

Lu, Jun-Lin; Xia, Qi-Dong; Liu, Chen-Qian; Sun, Jian-Xuan; Yang, Yuan-Yuan; Hu, Heng-Long; Wang, Shao-Gang.

Afiliación

Lu JL; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xia QD; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu CQ; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Sun JX; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yang YY; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hu HL; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang SG; Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Transl Cancer Res ; 10(6): 2849-2858, 2021 Jun.

Article en En | MEDLINE | ID: mdl-35116595

Palabras clave

Bacille Calmette-Guérin (BCG); Gemcitabine; meta-analysis; non-muscle invasive bladder cancer (NMIBC); tumor recurrence

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Transl Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google